Monarsen

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameMonarsen
Drug Alias NameBL-7040EN-101
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionAcetylcholinesterase inhibitorsToll like receptor 9 agonists
TargetsToll like receptor 9Acetylcholinesterase
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesYissum
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiolinerx Ltd
Active IndicationsN/A
Inactive IndicationsColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A